Banner - NPPA Connect
Opinion|Videos|December 9, 2024

Primary and Secondary Endpoints

Key Takeaways

Panelists discuss how the primary endpoint of the Effisayil 2 trial focused on the time to first GPP flare, while secondary endpoints assessed flare severity, quality of life, and inflammatory markers, providing a comprehensive evaluation of spesolimab's impact on GPP management.